deaths from tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes SUMMIT: Tirzepatide a 'Huge Win'

Factors That Influence Your Individual Weight Loss Results Genetic variations in peptide receptors and appetite-regulating pathways significantly impact how effectively your body responds to GLP-1 therapy

When patients search for Semaglutide eligibility, one of the most common questions is whether they meet the BMI requirements necessary for treatment

Both medications can cause gastrointestinal symptoms, particularly nausea

Regulatory review for additional oral GLP-1 options is anticipated in the coming years, potentially as early as 2026

[1] It is a ubiquitous compound with a biologically active sulfhydryl group contributed by the cysteine moiety that acts as the active part of the molecule